Unichem Lab share price has zoomed 5% and is presently trading at Rs 568.5.
Meanwhile, the BSE HEALTHCARE index is at 40,491.0 (up 0.8%).
Among the top gainers in the BSE HEALTHCARE index today are SUVEN PHARMACEUTICALS (up 10.6%) and GRANULES INDIA (up 5.3%).
POLY MEDICURE (down 1.8%) and J.B.Chemicals (down 1.5%) are among the top losers today.
Over the last one year, Unichem Lab has moved up from Rs 395.1 to Rs 568.5, registering a gain of Rs 173.5 (up 43.9%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,736.5 to 40,491.0, registering a gain of 46.0% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were SUVEN PHARMACEUTICALS (up 111.7%), Jubilant Pharmova (up 103.5%) and GSK Pharma (up 98.4%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 81,732.1 (up 0.3%).
The top gainers among the BSE Sensex today are Asian Paints (up 2.7%) and JSW Steel (up 1.9%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 24,937.8 (up 0.3%). Asian Paints and NTPC are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 66,527.7 to 81,732.1, registering a gain of 15,204.4 points (up 22.9%).
Unichem Lab net profit fell 192.1% YoY to Rs -1,293 million for the quarter ended March 2024, compared to a loss of Rs 443 million a year ago. Net sales rose 7.4% to Rs 4,317 million during the period as against Rs 4,021 million in January-March 2023.
For the year ended March 2024, Unichem Lab reported 65.2% increase in net profit to Rs -705 million compared to net loss of Rs 2,022 million during FY23. Revenue of the company grew 26.9% to Rs 17,049 million during FY24.
The current Price to earnings ratio of Unichem Lab, based on rolling 12 month earnings, stands at -56.8.
Equitymaster requests your view! Post a comment on "Unichem Lab Gains 5%; BSE HEALTHCARE Index Up 0.8%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!